Answer:
a. VIP (vasoactive intestinal peptide)
Explanation:
The enteric nervous system (ENS) is one of the main divisions of the autonomic nervous system (ANS) together with sympathetic and parasympathetic nervous system. This system consists of neurons that regulate the function of the gastrointestinal tract (GI).
Inhibitory interneurons that are part of the enteric nervous system also known as Dogiel type I neurones achieve their inhibitory transmission via nitric oxide, adenosine triphosphate, vasoactive intestinal peptide (VIP) and pituitary activating cyclic AMP. They usually act directly on smooth muscles of GI.
The answer is hox gene.
Hox genes are responsible for an embryo's body plan. They determine different body structures - legs, vertebrae, antennae, wings, depending on groups. Mutation in hox genes is serious mutation since it affects the early stages of embryo and consequently, normal development. If a mutation occurs in the hox gene for legs growth, the legs will not develop.
The second one probably because of the law of conservation of mass where mass is not created or destroyed, so the mass has to be the same.
<u>Stem cell </u>research has the potential to significantly impact the development of disease-modifying treatments for Parkinson’s disease with considerable progress made in creating dopamine-progressing cells.
Explanation:
Parkinson’s disease, a neurodegenerative disease, leads to reduction of dopamine (a neurochemical messenger which carries messages involving thinking and body movements to brain) in the body because the disease will target and kill dopamine-producing nerve cells (neurons). This leads to loss of movement and thinking abilities which are activated by dopamine.
Stem cells research is done to study about the prospects of stem cells in stem cell therapy for Parkinson’s patients as a viable source of new dopamine nerve cells. Research has been involved in growing stem cells to replace or regenerate dopamine-producing nerve cells by using embryonic stem cells or induced pluripotent stem cells as a treatment modality in Parkinson’s disease.
I think this is what you are referring to.
Hope this helps.
